Suberoylanilide hydroxamic acid (SAHA), a potential treatment and HDAC inhibitor, induced autophagy in cancer cells while blocking the Akt/mTOR pathway and inducing the endosplasmic reticulum stress response. This evidence concerns the gene AKT1 and cancer.